Scabies-infested Pregnant Women: A Critical Therapeutic Challenge

Overview

Journal PLoS Negl Trop Dis

Specialties Infectious Diseases
Tropical Medicine

Date 2021 Jan 7

PMID 33411710

Citations 7

Authors

Amandine Weill

Charlotte Bernigaud

Mourad Mokni

Sophie Gil

Elisabeth Elefant

Olivier Chosidow

Affiliations

Soon will be listed here.

Citing Articles

Scabies.

Fernando D, Mounsey K, Bernigaud C, Surve N, Estrada Chavez G, Hay R Nat Rev Dis Primers. 2024; 10(1):74.

PMID: 39362885 DOI: 10.1038/s41572-024-00552-8.

Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions.

Simonart T, Lam Hoai X J Clin Med. 2024; 13(18).

PMID: 39336998 PMC: 11432065. DOI: 10.3390/jcm13185511.

Clinical practice guidelines for the diagnosis and treatment of scabies.

Uzun S, Durdu M, Yurekli A, Mulayim M, Akyol M, Velipasaoglu S Int J Dermatol. 2024; 63(12):1642-1656.

PMID: 38922701 PMC: 11589009. DOI: 10.1111/ijd.17327.

Pruritus in Pregnancy.

Shrikhande L, Kadu P J Obstet Gynaecol India. 2024; 74(1):12-21.

PMID: 38434130 PMC: 10901761. DOI: 10.1007/s13224-024-01957-x.

Treatment of Pregnant Women with Ivermectin during Mass Drug Distribution: Time to Investigate Its Safety and Potential Benefits.

Erber A, Ariyo E, Olliaro P, Nicolas P, Chaccour C, Colebunders R Pathogens. 2021; 10(12).

PMID: 34959543 PMC: 8703637. DOI: 10.3390/pathogens10121588.

References

Mytton O, McGready R, Lee S, Roberts C, Ashley E, Carrara V . Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study. BJOG. 2007; 114(5):582-7. DOI: 10.1111/j.1471-0528.2007.01290.x. View

Rosumeck S, Nast A, Dressler C . Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018; 4:CD012994. PMC: 6494415. DOI: 10.1002/14651858.CD012994. View

Mounsey K, Bernigaud C, Chosidow O, McCarthy J . Prospects for Moxidectin as a New Oral Treatment for Human Scabies. PLoS Negl Trop Dis. 2016; 10(3):e0004389. PMC: 4795782. DOI: 10.1371/journal.pntd.0004389. View

Porto I . Antiparasitic drugs and lactation: focus on anthelmintics, scabicides, and pediculicides. J Hum Lact. 2003; 19(4):421-5. DOI: 10.1177/0890334403258133. View

Strong M, Johnstone P . Interventions for treating scabies. Cochrane Database Syst Rev. 2007; (3):CD000320. PMC: 6532717. DOI: 10.1002/14651858.CD000320.pub2. View

Gil S, Saura R, Forestier F, Farinotti R . P-glycoprotein expression of the human placenta during pregnancy. Placenta. 2005; 26(2-3):268-70. DOI: 10.1016/j.placenta.2004.05.013. View

Nicolas P, Maia M, Bassat Q, Kobylinski K, Monteiro W, Rabinovich N . Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis. Lancet Glob Health. 2019; 8(1):e92-e100. PMC: 7613514. DOI: 10.1016/S2214-109X(19)30453-X. View

Baudou E, Lespine A, Durrieu G, Andre F, Gandia P, Durand C . Serious Ivermectin Toxicity and Human Nonsense Mutations. N Engl J Med. 2020; 383(8):787-789. DOI: 10.1056/NEJMc1917344. View

Sappenfield E, Jamieson D, Kourtis A . Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol. 2013; 2013:752852. PMC: 3723080. DOI: 10.1155/2013/752852. View

10.

Chosidow O, Hay R . Control of scabies and secondary impetigo: optimising treatment effectiveness in endemic settings. Lancet Infect Dis. 2019; 19(5):454-456. DOI: 10.1016/S1473-3099(19)30068-4. View

11.

Roger D, Vaillant L, Fignon A, Pierre F, Bacq Y, Brechot J . Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women. Arch Dermatol. 1994; 130(6):734-9. View

12.

Jamieson D, Theiler R, Rasmussen S . Emerging infections and pregnancy. Emerg Infect Dis. 2007; 12(11):1638-43. PMC: 3372330. DOI: 10.3201/eid1211.060152. View

13.

Bernigaud C, Fang F, Fischer K, Lespine A, Aho L, Dreau D . Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model. PLoS Negl Trop Dis. 2016; 10(10):e0005030. PMC: 5061321. DOI: 10.1371/journal.pntd.0005030. View

14.

Lankas G, Wise L, Cartwright M, Pippert T, Umbenhauer D . Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol. 1998; 12(4):457-63. DOI: 10.1016/s0890-6238(98)00027-6. View

15.

Berveiller P, Gil S, Vialard F . Placental perfusion: interest and limits. J Matern Fetal Neonatal Med. 2016; 30(11):1347-1348. DOI: 10.1080/14767058.2016.1213807. View

16.

Salavastru C, Chosidow O, Boffa M, Janier M, Tiplica G . European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017; 31(8):1248-1253. DOI: 10.1111/jdv.14351. View

17.

Kennedy D, HURST V, Konradsdottir E, Einarson A . Pregnancy outcome following exposure to permethrin and use of teratogen information. Am J Perinatol. 2005; 22(2):87-90. DOI: 10.1055/s-2005-837736. View

18.

. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1545-1602. PMC: 5055577. DOI: 10.1016/S0140-6736(16)31678-6. View

19.

Hutson J, Garcia-Bournissen F, Davis A, Koren G . The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs. Clin Pharmacol Ther. 2011; 90(1):67-76. DOI: 10.1038/clpt.2011.66. View

20.

Ogbuokiri J, Ozumba B, Okonkwo P . Ivermectin levels in human breastmilk. Eur J Clin Pharmacol. 1993; 45(4):389-90. DOI: 10.1007/BF00265962. View